Schedule 13D ownership disclosure
CYCLERION THERAPEUTICS INC
Security class unavailable · CUSIP: 23255M204
Event date: 2023-05-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 518,464
- Percent of class
- 19.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-063613
- Form type
- SC 13D
- Filer
- Cyclerion Therapeutics, Inc.
- CIK
- CIK 1755237
- Filed
- May 23, 2023
- Reporting period
- May 19, 2023
- Description
- Schedule 13D beneficial ownership